Holen Sie sich die Stockscreener-App
33.83
7.54%
-2.9068
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
SLNO Investors Urged to Join Soleno Therapeutics Securities Fraud Lawsuit - National Today
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law - GlobeNewswire
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit: Investors Face May 5, 2026, Deadline - GlobeNewswire
SLNO Shareholder Alert: May 5, 2026 Lead Plaintiff Deadline - GlobeNewswire
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP - The AI Journal
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman - PR Newswire
Soleno Therapeutics Investors Encouraged to Contact Kaplan Fox Before Deadline - National Today
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO) - ACCESS Newswire
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, I - The National Law Review
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action - The AI Journal
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, Inc. (SLNO) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2026 - The Globe and Mail
FinancialContentSOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, Inc. (SLNO) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2026 - FinancialContent
SLNO Lawsuit Alleges Allegedly Conducting Sham Clinical TrialsSoleno Therapeutics, Inc. Investors Face Losses Following Allegedly Conducting Sham Clinical Trials: SueWallSt - Stock Titan
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno ... - Bluefield Daily Telegraph
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT - GlobeNewswire
SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of ... - Caledonian Record
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - GlobeNewswire Inc.
Soleno Therapeutics, Inc. Class Action Notice: Robbins LLP - GlobeNewswire
INVESTOR NOTICE: Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - marketscreener.com
Law Offices of Howard G. Smith Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action - WFMZ.com
Law Offices of Frank R. Cruz Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action - The AI Journal
SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SLNO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 – Company AnnouncementFT.com - Financial Times
Soleno Therapeutics Faces Class Action Lawsuit Deadline - National Today
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application - GlobeNewswire
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO)Deadline is May 5, 2026 - NewMediaWire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Soleno - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
SOLENO THERAPEUTICS, INC. (SLNO) INVESTOR ALERT Investors With Large Losses in Soleno ... - Bluefield Daily Telegraph
SOLENO THERAPEUTICS, INC. (SLNO) INVESTOR ALERT Investors - GlobeNewswire
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch DisruptionsHagens Berman - The Malaysian Reserve
Soleno Therapeutics Investors Eligible to Lead Securities Fraud Lawsuit - National Today
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
(SLNO) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
2026-03-10 | SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics stock hits 52-week low at 37.95 USD - Investing.com Nigeria
Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors - WFMZ.com
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - WFXG
HC Wainwright lowers PT on Soleno (SLNO), keeps a buy rating - MSN
Soleno Therapeutics (SLNO) Faces Securities Class Action - GlobeNewswire
H.C. Wainwright Lowers PT on Soleno (SLNO), Keeps a Buy Rating - Bitget
Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
Securities Class Action Filed Against Soleno Therapeutics - Intellectia AI
Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026 - FinancialContent
Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SOLENO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus
Soleno Investor Sues Over Stock Plunge After Short-Seller Report - Bloomberg Law News
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):